Gelsemium Sempervirens, Nux Vomica, Bryonia Alba, Rhus Toxicodendron, Sabadilla, Euphrasia Officinalis, Allium Cepa, Aconitum Napellus, Pulsatilla Nigrans Powder
NDC Package 73296-006-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Gelsemium Sempervirens, Nux Vomica, Bryonia Alba, Rhus Toxicodendron, Sabadilla, Euphrasia Officinalis, Allium Cepa, Aconitum Napellus, Pulsatilla Nigrans powders is a drug for further processing. This formulation utilizes a powder delivery system. Marketed by Laboratoire Schmidt-nagel, this product is identified by NDC 73296-006.

Identification & Billing

NDC Package Code
73296-006-10
Package Description
1 BAG in 1 PAIL / 10 kg in 1 BAG
Product Code
73296-006
11-Digit Billing Format
73296000610

Clinical Specifications

Proprietary Name
Gelsemium Sempervirens, Nux Vomica, Bryonia Alba, Rhus Toxicodendron, Sabadilla, Euphrasia Officinalis, Allium Cepa, Aconitum Napellus, Pulsatilla Nigrans
Non-Proprietary Name
Gelsemium Sempervirens, Nux Vomica, Bryonia Alba, Rhus Toxicodendron, Sabadilla, Euphrasia Officinalis, Allium Cepa, Aconitum Napellus, Pulsatilla Nigrans
Substance Name
Aconitum Napellus; Anemone Pratensis; Bryonia Alba Root; Euphrasia Stricta; Gelsemium Sempervirens Root; Onion; Schoenocaulon Officinale Seed; Strychnos Nux-vomica Seed; Toxicodendron Pubescens Leaf
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Laboratoire Schmidt-nagel
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
09-17-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73296-006-10 identifies a specific commercial package of 1 bag in 1 pail / 10 kg in 1 bag of Gelsemium Sempervirens, Nux Vomica, Bryonia Alba, Rhus Toxicodendron, Sabadilla, Euphrasia Officinalis, Allium Cepa, Aconitum Napellus, Pulsatilla Nigrans (UNFINISHED drug), drug for further processing labeled by Laboratoire Schmidt-nagel. This powder is formulated for use and contains aconitum napellus; anemone pratensis; bryonia alba root; euphrasia stricta; gelsemium sempervirens root; onion; schoenocaulon officinale seed; strychnos nux-vomica seed; toxicodendron pubescens leaf as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Laboratoire Schmidt-nagel on September 17, 2019. The current certification is valid through December 31, 2026.

How is this Laboratoire Schmidt-nagel product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73296000610. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73296-006-10
11-Digit CMS (5-4-2)
73296-0006-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.